Apex Capital’s Orexigen Therapeutics OREX Stock Holding History
Bought
Maintained
Sold
Other funds holding OREX
Apex Capital's OREX Position: Q1 2014 in Review
Apex Capital sold out of Orexigen Therapeutics (OREX) in Q1 2014, closing a stake of 100,000 shares — an estimated $5.63M sold.
Apex Capital first reported a position in OREX in Q2 2013 and held it in 3 quarters. The position peaked at $6.39M in Q2 2013. 129 funds tracked by Wall St. Rank hold OREX as of Q1 2014.
- Apex Capital reported no remaining Orexigen Therapeutics position as of Q1 2014 after selling out during the quarter.
- Apex Capital sold 100,000 Orexigen Therapeutics shares in Q1 2014, an estimated $5.63M.
- Apex Capital first reported a position in Orexigen Therapeutics in Q2 2013 and held it in 3 quarters.
- Apex Capital's Orexigen Therapeutics position peaked at $6.39M in Q2 2013.
- 129 funds tracked by Wall St. Rank held Orexigen Therapeutics as of Q1 2014.
Based on Apex Capital's 13F filing for Q1 2014, filed 12 May 2014.